9 November 2026
Swissmedic: NAD+ Supplements – When Lifestyle Products Have Criminal Consequences
Swissmedic has highlighted the regulatory and criminal law risks associated with NAD+ products marketed for anti-ageing and longevity treatments. In Switzerland, products intended for injection or infusion with pharmacologically active properties are classified as medicinal products and may only be placed on the market if they comply with therapeutic products legislation. In several recent cases involving the import, distribution, advertising and use of unauthorised NAD+ preparations, Swissmedic initiated administrative criminal proceedings. Convictions resulted in fines or financial penalties of up to CHF 20’000.00 and the seizure of unlawfully obtained financial benefits of up to CHF 40’000.00. Swissmedic emphasised that the legal availability of comparable products abroad or their administration under medical supervision does not exempt them from Swiss therapeutic products requirements.
For more information, see here.